DeepValue Capital presents a bullish thesis on Baxter International Inc. (BAX), trading at $22.44 on August 4th. With a trailing P/E of 84.46 and forward P/E of 8.71, the company’s shares have dropped over 75%, presenting a potential turnaround opportunity in the healthcare sector. New CEO Andrew Hider aims to drive margin expansion and growth.

Baxter International (BAX) has divested non-core assets, generating $3 billion in proceeds for strategic reinvestment. CEO Andrew Hider plans to streamline operations, cut costs, and invest in next-gen healthcare solutions. Industry tailwinds and near-term catalysts support a potential 250% return by 2028, with shares exceeding $70.

Despite a 10.3% stock price decline, Intuitive Surgical, Inc. (ISRG) remains a dominant player in robotic surgery. The Antifragile Investor’s bullish thesis on ISRG highlights its strong IP moat and recurring revenue model. DeepValue Capital sees value in healthcare innovation, with Baxter’s restructuring and leadership change offering a compelling turnaround story.

Read more at Yahoo Finance: Baxter International Inc. (BAX): A Bull Case Theory